Clinical trials
Women clinical trials
Below are recruiting women clinical trials, each written for real people, not researchers. We’re tracking 1,334 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06659315Recruiting
Preventing HIV transmission from mom to baby for depressed mothers in Malawi
This study tests a program to help pregnant women with HIV who also have depression, and their partners, reduce the risk of passing HIV to their babies. The program includes support for mental health and HIV care.
ZombaAges 18 years+ - NCT06666530Recruiting
Quality of life for pregnant women with HIV
This study looks at how being pregnant while living with HIV affects your quality of life and the care you receive. It aims to understand your experiences and needs during this time.
ParisAges 18 years+ - NCT05739123Recruiting
Pregnancy safety registry for relugolix-containing medicines
This is an observational study that collects real-world information about pregnancy outcomes when relugolix-containing therapy is taken during pregnancy. It aims to better understand safety for both the parent during pregnancy and the child after birth.
Wilmington, North CarolinaAges birth+ - NCT06648174Recruiting
Managing heart health risk after gestational diabetes
This study tests a program to help women who had gestational diabetes reduce their future risk of heart disease and diabetes. It checks if monitoring and support can improve health after pregnancy.
HsinchuAges 18 years+ - NCT06648018Enrolling by invitation
Iron supplement vs. nutrition advice in healthy women
This study compares taking an iron supplement to receiving nutritional advice in healthy women who menstruate and exercise regularly. The goal is to see which approach better supports iron levels and overall health.
LinköpingAges 20–40 - NCT06652113Recruiting
Hydroxychloroquine with thyroid hormone for recurrent pregnancy loss
This study tests whether a combination of hydroxychloroquine (an anti-inflammatory drug) and levothyroxine (thyroid hormone) can improve live birth rates in women with recurrent pregnancy loss, normal thyroid function, and TPO antibodies.
Guangzhou, GuangdongAges 20–40 - NCT06647511Recruiting
Digital health study for pregnant refugees in NYC
This study tests a smartphone-based tool to help pregnant refugees and asylum seekers stay healthy during pregnancy. It aims to reduce complications and improve care for mothers and babies.
New York, New YorkAges 18 years+ - NCT06653426Recruiting
The effect of NaBu on menstrual symptoms
This study tests whether taking a supplement called NaBu can help reduce menstrual symptoms. It may be an option if you have bothersome period symptoms like cramps or bloating.
Chicago, IllinoisAges 18 years+ - NCT06641466RecruitingPhase 3
Study of Rimegepant for preventing menstrual migraine in women
This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.
Phoenix, ArizonaAges 18–45 - NCT06632535Recruiting
Group visits and chiropractic care for older adults with chronic spine pain
This study tests whether group medical visits combined with chiropractic care can help older adults with chronic neck or back pain. If you join, you'll receive chiropractic treatments and attend group visits to learn pain management strategies.
Boston, MassachusettsAges 65 years+ - NCT06636370Recruiting
Extra screening for women with dense breast tissue
This trial offers extra screening (MRI or contrast-enhanced mammogram) for women with extremely dense breast tissue who have had a normal mammogram. The goal is to see if these extra tests can find cancers that might be missed by standard mammography.
UtrechtAges 49–72 - NCT06639464RecruitingPhase 2
Semaglutide for improving opioid recovery outcomes
This study tests whether semaglutide (a medication used for weight management) can help people on buprenorphine or methadone reduce their opioid use. If it works, it could provide additional support during recovery.
Boston, MassachusettsAges 18 years+ - NCT06629896Recruiting
Comparing contrast mammogram vs MRI for high-risk breast cancer surveillance
This trial compares two advanced imaging methods—contrast-enhanced mammography and MRI—to see which is better for detecting breast cancer early in women at high risk. If you are at high risk and have not had breast cancer before, this study could help guide your future screening.
Reggio Emilia, Italy/Reggio EmiliaAges 35–60 - NCT05762952RecruitingPhase 1
Dapagliflozin study for heart micro-blood-flow symptoms in women
This early-phase study tests whether dapagliflozin can improve tiny blood-vessel function in women who have heart-ache-like symptoms but no major blockage on heart scans. If it works, it may help symptoms related to “microvascular” heart circulation problems.
Charlottesville, VirginiaAges 18–99 - NCT06628973Recruiting
Social activities for women with heart failure
This trial tests a social program to help women with heart failure better stick with their medications and feel healthier. You'll be connected to community activities and support tailored to your needs.
Montreal, QuebecAges 18 years+ - NCT06627335Recruiting
Eczema creams and pregnancy outcomes study
This study looks at women who used a topical eczema cream called ruxolitinib (Opzelura) or steroid creams during pregnancy. The goal is to compare pregnancy outcomes and baby health up to one year after birth.
Morrisville, North CarolinaAges 14 years+ - NCT06610305RecruitingPhase 4
Hormones, mood, and reward in women with PMS-related depression
This study looks at how changes in hormone levels during the menstrual cycle affect mood and the brain's reward system in women with depression that gets worse before their period. The goal is to understand why this happens so better treatments can be developed.
Chapel Hill, North CarolinaAges 18–45 - NCT05937841RecruitingEarly Phase 1
Test how a blood-pressure hormone receptor works after preeclampsia
This early study looks at how “angiotensin II” receptors behave in women after preeclampsia compared with women who didn’t have it. It may help researchers understand long-term health risks after pregnancy and guide future treatments.
Iowa City, IowaAges 18–45 - NCT04167748Recruiting
Genetic testing for embryos in IVF for women 35–40
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
Margate, FloridaAges 35–40 - NCT06598553Enrolling by invitation
Preventing violence against women and girls in Madagascar
This study tests programs in middle schools to help prevent violence against women and girls. It looks at whether the programs work for students, teachers, and school directors.
FiananransoaAges 10 years+ - NCT06600178RecruitingPhase 1
Heart medication for women with chest pain and small vessel disease
This trial tests a diabetes medication called SGLT2 inhibitors to see if it can improve blood flow to the heart and reduce chest pain in women who have small vessel heart disease (microvascular dysfunction) but not blocked large arteries. Participants will take the medication and be monitored for symptom relief and heart function improvements.
Charlottesville, VirginiaAges 18 years+ - NCT06575309Recruiting
Blood clotting in pregnancy and the effect of blood thinner
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
Clermont-FerrandAges 18–55 - NCT06581601Recruiting
Physiotherapy for women with urinary incontinence
This trial tests whether physiotherapy can help women with urinary incontinence. It compares a treatment group to a group of healthy women.
PoznanAges 20–80 - NCT06576089Recruiting
Stroke recovery rehab trial testing Maraviroc vs. placebo
This trial tests if the drug Maraviroc (compared to a placebo) can improve stroke recovery when added to standard rehabilitation. It is for people who have had a specific type of stroke (ischemic anterior circulation) and have weakness on one side of the body, and are already in inpatient rehab.
Calgary, AlbertaAges 18 years+
Hear when a new Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for women?
- Yes. Clin2 currently lists 1,334 recruiting women studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a women trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a women trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.